Quadratus Lumborum Plain Block Versus Fascia Iliac Block

NCT ID: NCT05920265

Last Updated: 2023-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Operative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Quadratus Lumborum Block

Group Type EXPERIMENTAL

Quadratus Lumborum plain Block

Intervention Type PROCEDURE

ultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% .

Fascia Iliac Block

Group Type EXPERIMENTAL

fascia iliaca block

Intervention Type PROCEDURE

ultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25%

control

Group Type ACTIVE_COMPARATOR

control group

Intervention Type DIAGNOSTIC_TEST

no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quadratus Lumborum plain Block

ultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% .

Intervention Type PROCEDURE

fascia iliaca block

ultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25%

Intervention Type PROCEDURE

control group

no intervention

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-70 years
* fracture hip

Exclusion Criteria

* patients refuse
* mental problem patient with any coagulation deficiency or bleeding problems patient with allergy to investigated medications,
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hassan Mokhtar Elshorbagy Hetta

lecturer of anesthesia and ICU

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

abeer M hassaneen, Ass. professor

Role: STUDY_DIRECTOR

minia university hospital/ faculty of medicine

ahmed H Mohamed, Professor

Role: STUDY_CHAIR

minia university hospital/ faculty of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minia University

Minya, Minya Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16:2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.